Evidence map›Paper›PMID 23736024›Full record

ArticleNature communications2013

The basis for limited specificity and MHC restriction in a T cell receptor interface.

Kurt H Piepenbrink, Sydney J Blevins, Daniel R Scott, Brian M Baker

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Human c-SRC kinase (CSK) overexpression makes T cells dummy.Cancer immunology, immunotherapy : CII · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kurt H PiepenbrinkDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Sydney J Blevins
Daniel R Scott
Brian M Baker
University of Notre Dame · US

Funding

Chemistry-Biochemistry-Biology Training Program at Notre DameT32GM075762 · NIGMS · UNIVERSITY OF NOTRE DAME · PI CHANG, MAYLAND F, MOBASHERY, SHAHRIAR · 2007 to 2021
$3.7M
Physical Basis for T Cell Receptor Binding and ActivityR01GM067079 · NIGMS · UNIVERSITY OF NOTRE DAME · PI BAKER, BRIAN M · 2003 to 2015
$3.5M
NIGMS NIH HHS GM067079NIGMS NIH HHS GM075762NIGMS NIH HHS R01 GM067079NIGMS NIH HHS T32 GM075762
6 · The paper itself

Abstract

αβ T cell receptors (TCRs) recognize peptides presented by major histocompatibility complex (MHC) proteins using multiple complementarity-determining region (CDR) loops. TCRs display an array of poorly understood recognition properties, including specificity, crossreactivity and MHC restriction. Here we report a comprehensive thermodynamic deconstruction of the interaction between the A6 TCR and the Tax peptide presented by the class I MHC HLA-A*0201, uncovering the physical basis for the receptor's recognition properties. Broadly, our findings are in conflict with widely held generalities regarding TCR recognition, such as the relative contributions of central and peripheral peptide residues and the roles of the hypervariable and germline CDR loops in engaging peptide and MHC. Instead, we find that the recognition properties of the receptor emerge from the need to engage the composite peptide/MHC surface, with the receptor utilizing its CDR loops in a cooperative fashion such that specificity, crossreactivity and MHC restriction are inextricably linked.

Indexed as

Complementarity Determining RegionsConserved SequenceGene Products, taxHLA-A2 AntigenHumansMajor Histocompatibility ComplexModels, MolecularMutant ProteinsMutationPeptidesProtein BindingProtein Structure, SecondaryReceptors, Antigen, T-CellComplementarity Determining RegionsGene Products, taxHLA-A2 AntigenMutant ProteinsPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID23736024
PMCPMC3708045
OpenAlexW2084653587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.